Product Data Sheet

Empagliflozin impurity 83

Catalog No. A99538

main product photo
Empagliflozin impurity 83 is a characterized impurity associated with the SGLT2 inhibitor Empagliflozin. It serves as an important reference standard in the analysis of drug purity and quality control. This compound is essential for researchers engaged in the development of pharmaceuticals, particularly in ensuring the integrity and compliance of SGLT2 inhibitor formulations.
Chemical Information
Catalog NumA99538
M. Wt381.65
FormulaC17H14BrClO3
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.915095-84-0
Synonyms
SMILESO=C(C1=CC(Br)=CC=C1Cl)C2=CC=C(O[C@@H]3COCC3)C=C2
Biological Activity
DescriptionEmpagliflozin impurity 83 is a characterized impurity associated with the SGLT2 inhibitor Empagliflozin. It serves as an important reference standard in the analysis of drug purity and quality control. This compound is essential for researchers engaged in the development of pharmaceuticals, particularly in ensuring the integrity and compliance of SGLT2 inhibitor formulations.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.